» Articles » PMID: 34663382

Overexpression of FGF2 Delays the Progression of Osteonecrosis of the Femoral Head Activating the PI3K/Akt Signaling Pathway

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2021 Oct 19
PMID 34663382
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of the current study was to explore the role and underlying mechanism of FGF-2 in dexamethasone (DEX)-induced apoptosis in MC3T3-E1 cells.

Methods: GSE21727 was downloaded from the Gene Expression Omnibus (GEO) database to identify the differentially expressed genes (DEGs) by the limma/R package. MC3T3-E1 cells were exposed to DEX at different concentrations (0, 10, 10, 10, 10 and 10 mol/L), and cell viability, flow cytometry and TUNEL assay were used to detect cell proliferation and apoptosis. An FGF-2-pcDNA3 plasmid (oe-FGF-2) was used to overexpress FGF-2, and western blotting was conducted to detect protein expression.

Results: We found that FGF-2 was downregulated in the DEX-treated group. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses indicated that DEGs were associated with PI3K/Akt signaling pathway. DEX downregulated FGF-2 gene and protein expression, inhibited viability and induced MC3T3-E1 cell apoptosis. Overexpression of FGF-2 reversed DEX-induced apoptosis in MC3T3-E1 cells. FGF-2-mediated anti-apoptosis was impaired by inactivating the PI3K/AKT pathway with LY294002. Moreover, overexpression of FGF2 delayed the progression of DEX-induced osteonecrosis of the femoral head (ONFH) animal model by regulation PI3K/Akt signaling pathway.

Conclusion: In conclusion, FGF-2 is effective at inhibiting DEX-induced MC3T3-E1 cell apoptosis through regulating PI3K/Akt signaling pathway.

Citing Articles

Fibroblast growth factor 23 regulates hypoxia‑induced osteoblast apoptosis through the autophagy‑signaling pathway.

Yin Q, Yang H, Fang L, Wu Q, Gao S, Wu Y Mol Med Rep. 2023; 28(5).

PMID: 37711045 PMC: 10540001. DOI: 10.3892/mmr.2023.13086.

References
1.
Wu X, Sun W, Tan M . Noncoding RNAs in Steroid-Induced Osteonecrosis of the Femoral Head. Biomed Res Int. 2020; 2019:8140595. PMC: 6942769. DOI: 10.1155/2019/8140595. View

2.
Ding H, Wang T, Xu D, Cha B, Liu J, Li Y . Dexamethasone-induced apoptosis of osteocytic and osteoblastic cells is mediated by TAK1 activation. Biochem Biophys Res Commun. 2015; 460(2):157-63. DOI: 10.1016/j.bbrc.2015.02.161. View

3.
Yang X, Kui L, Tang M, Li D, Wei K, Chen W . High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery. Front Genet. 2020; 11:19. PMC: 7013098. DOI: 10.3389/fgene.2020.00019. View

4.
Zhao D, Zhang F, Wang B, Liu B, Li L, Kim S . Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J Orthop Translat. 2020; 21:100-110. PMC: 7152793. DOI: 10.1016/j.jot.2019.12.004. View

5.
Okada T, Enkhjargal B, Travis Z, Ocak U, Tang J, Suzuki H . FGF-2 Attenuates Neuronal Apoptosis via FGFR3/PI3k/Akt Signaling Pathway After Subarachnoid Hemorrhage. Mol Neurobiol. 2019; 56(12):8203-8219. PMC: 6842096. DOI: 10.1007/s12035-019-01668-9. View